Clinical Trials

EE-CSWS

Neurocrine Biosciences is conducting a Phase II STEAMBOAT™, double-blind study to assess the safety, tolerability, and pharmacokinetics of NBI-827104 in pediatric patients with Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep (EE-CSWS). For more information about this Phase II study of NBI-827104, please visit https://stillwaterprogram.com/ or clinicaltrials.gov.

Essential Tremor

Neurocrine Biosciences is conducting a Phase II, randomized, double-blind placebo-controlled, crossover study to assess the safety, tolerability, pharmacokinetics and efficacy of NBI-827104 in adult patients with essential tremor in the Netherlands. For more information about this Phase II study of NBI-827104, please visit clinicaltrials.gov.